A total of 1723 individuals presented for testing (75% male; 31% MSM). MSM were more likely to test HIV positive than heterosexual men or women. Among 538 MSM, we identified four latent classes.
- Class 1 had the highest rates of incarceration (33%), forced sex (24%), but had no HIV infections.
- Class 2 had <5 anal sex partners in the previous 12 months, the lowest rates of drug/alcohol use during sex and lower HIV prevalence (3%).
- Class 3 had the highest prevalence of HIV (7%) and other STDs (16%), > 10 anal sex partners in the previous 12 months (69%), anonymous partners (100%), drug/alcohol use during sex (76%), and prior STDs (40%).
- Class 4 had similar characteristics and HIV prevalence as Class 2. In this population, MSM who may benefit most from PrEP include those who have >10 sexual partners per year, anonymous partners, drug/alcohol use during sex and prior STDs.
Purchase full article at: http://ht.ly/Sy82s
By: Chan PA1, Rose J2, Maher J1, Benben S1, Pfeiffer K1, Almonte A1, Poceta J1, Oldenburg CE3, Parker S4, Marshall BD5, Lally M1, Mayer K6, Mena L7, Patel R8,Nunn AS9.
- 11 Division of Infectious Diseases, Department of Medicine, Alpert Medical School of Brown University , Providence, Rhode Island.
- 22 Department of Psychology, Wesleyan University , Middletown, Connecticut.
- 33 Department of Epidemiology, Harvard T.H. Chan School of Public Health , Cambridge, Massachusetts.
- 44 Department of Social Work, North Carolina Agricultural and Technical State University , Greensboro, North Carolina.
- 55 Department of Epidemiology, Brown University School of Public Health , Providence, Rhode Island.
- 66 Fenway Health, The Fenway Institute , Boston, Massachusetts.
- 77 Division of Infectious Diseases, University of Mississippi Medical Center , Jackson, Mississippi.
- 88 Division of Infectious Diseases, Washington University in St. Louis School of Medicine , St. Louis, Missouri.
- 99 Department of Behavioral and Social Sciences, Brown University School of Public Health , Providence, Rhode Island.
More at: https://twitter.com/hiv_insight
No comments:
Post a Comment